HOME >> BIOLOGY >> NEWS
UT Southwestern scientist named Keck Foundation Distinguished Young Scholar in Medical Research

Dallas -- July 25, 2006 -- Dr. Russell DeBose-Boyd, assistant professor of molecular genetics at UT Southwestern Medical Center, has been named a Distinguished Young Scholar in Medical Research by the Los Angeles-based W.M. Keck Foundation.

The award of up to $1 million over five years will support the researcher's work on the enzymes that regulate and control cholesterol production, studies that may shed light on the prevention and treatment of heart disease.

"I'm honored to be included among such a distinguished group of young investigators," said Dr. DeBose-Boyd, one of five Keck Young Scholar winners nationwide this year. "This generous award will allow my lab to continue our efforts to understand the enzyme HMG CoA reductase, a key player in cholesterol synthesis and the target of cholesterol-lowering statin drugs.

"I'm grateful to the W.M. Keck Foundation for this support that allows young researchers to explore novel projects and take on new challenges in high-risk areas that could lead to important medical breakthroughs," he said.

A native of Boswell, Okla., Dr. DeBose-Boyd received his bachelor's degree in chemistry from Southeastern Oklahoma State University and his doctorate in biochemistry and molecular biology from the University of Oklahoma Health Sciences Center. Before joining the faculty of UT Southwestern as an instructor in 2001, he was a postdoctoral fellow in the molecular genetics laboratory of two of UT Southwestern's four Nobel laureates, Dr. Michael Brown and Dr. Joseph Goldstein. As a young faculty member at UT Southwestern Dr. DeBose-Boyd's early research was supported by the Perot Foundation.

Dr. DeBose-Boyd said being named a Keck Young Scholar is a reflection of the scientific environment in the Department of Molecular Genetics at UT Southwestern in general.

"This institution encourages young scientists, and provides tremendously talented mentors. I wouldn't be here if it w
'"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
25-Jul-2006


Page: 1 2 3

Related biology news :

1. UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus
2. UT Southwestern leaders to receive national award for medical research accomplishments
3. UT Southwestern scientist receives NIH Directors Pioneer Award
4. UT Southwestern researchers find gene mutation that leads to broken hearts
5. Plague agent helps UT Southwestern researchers find novel signaling system in cells
6. One of the nations first 7-Tesla magnetic resonance imaging devices for human studies planned at UT Southwestern Medical Center
7. DNA end caps may lead to cancer treatments, UT Southwestern researchers report
8. UT Southwestern scientist honored among best in Texas research
9. UT Southwestern scientist receives international award for pediatric research
10. UT Southwestern physician-researcher wins international award for lipid research
11. UT Southwestern scientist elected to National Academy of Sciences Institute of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2020)... ... May 26, 2020 , ... ... announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, ... TCR-based therapeutics, has implemented Genedata Biologics ® within their R&D organization. ...
(Date:5/21/2020)... Ga. (PRWEB) , ... May ... ... of Human Capital IntegritySM technology-based services specializing in background and medical screening, ... their COVID-19 return-to-work planning and keeping their workforce safe. The new service ...
(Date:5/21/2020)... , ... May 20, 2020 , ... ... manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, ... Gene Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, which ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... ... trials will cause long-term harm , Contrary to conventional wisdom that says the ... finds many companies will emerge from the pandemic commercially weaker, dealing with ...
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased to announce ... and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm. , This ... United States, linking US and Asia Pacific healthcare innovators with capital and investors. , ...
(Date:5/15/2020)... , ... May 14, 2020 ... ... of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess ... enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is ...
(Date:5/15/2020)... ... May 14, 2020 , ... This new service offers ... the most pressing questions answered quickly as the need arises. Lachman’s OnCall SMEs have ... advice at affordable rates. , Lachman OnCall™ SMEs are available normal business hours ...
Breaking Biology Technology:
Cached News: